Deal extends analytical instrumentation portfolio.
Genetix’ drug discovery division has joined forces with Molecular Devices. The deal grows Molecular Devices beyond a technology supply company for research, biotechnology, and pharmaceutical companies.
Founded in 1991, Genetix offers cell selection and cell imaging instrumentation and related products to basic and applied research scientists. The company’s key products are ClonePix™ and QPix™.
ClonePix is an automated mammalian cell selection platform that has been designed to expedite the identification and selection of cells that produce biotherapeutic candidates. QPix colony pickers are reportedly used worldwide in over 600 installations. In addition, the CloneSelect™ Imager and CellReporter from Genetix will extend Molecular Devices’ imaging portfolio.
Molecular Devices offers a variety of detection technologies that meet all throughput needs from dedicated, single-readout devices to multireadout systems. The firm’s analytical products, which are for research use only, are used in basic research and discovery. The company’s headquarters are in Silicon Valley, and it has offices around the globe.
